{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:36:57Z","timestamp":1780054617998,"version":"3.54.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1097\/inf.0000000000001176","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T17:20:47Z","timestamp":1461086447000},"page":"e220-e228","source":"Crossref","is-referenced-by-count":13,"title":["Long-term Serologic Follow-up of Children Vaccinated with a Pediatric Formulation of Virosomal Hepatitis A Vaccine Administered With Routine Childhood Vaccines at 12\u201315 Months of Age"],"prefix":"10.1097","volume":"35","author":[{"given":"Ron","family":"Dagan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shai","family":"Ashkenazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilat","family":"Livni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Sarnecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-17-20210202","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0140-6736(98)01304-X","article-title":"Hepatitis A.","volume":"351","author":"Koff","year":"1998","journal-title":"Lancet"},{"key":"R2-17-20210202","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/mem.2003.138","article-title":"Underuse of analgesia in very young pediatric patients with isolated painful injuries.","volume":"41","author":"Alexander","year":"2003","journal-title":"Ann Emerg Med"},{"key":"R3-17-20210202","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1086\/586899","article-title":"Declining hepatitis A mortality in the United States during the era of hepatitis A vaccination.","volume":"197","author":"Vogt","year":"2008","journal-title":"J Infect Dis"},{"key":"R4-17-20210202","doi-asserted-by":"crossref","first-page":"526","DOI":"10.3201\/eid1403.070900","article-title":"Control of hepatitis A by universal vaccination of adolescents, Puglia, Italy.","volume":"14","author":"Lopalco","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"R5-17-20210202","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1001\/jama.294.2.202","article-title":"Incidence of hepatitis A in Israel following universal immunization of toddlers.","volume":"294","author":"Dagan","year":"2005","journal-title":"JAMA"},{"key":"R6-17-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2807\/1560-7917.ES2015.20.7.21040","article-title":"The impact of a national routine immunisation programme initiated in 1999 on Hepatitis A incidence in Israel, 1993 to 2012.","volume":"20","author":"Levine","year":"2015","journal-title":"Euro Surveill"},{"key":"R8-17-20210202","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0264-410X(92)90506-F","article-title":"A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks.","volume":"10","author":"Just","year":"1992","journal-title":"Vaccine"},{"key":"R9-17-20210202","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0140-6736(94)91162-2","article-title":"Inactivated virosome hepatitis A vaccine.","volume":"343","author":"Loutan","year":"1994","journal-title":"Lancet"},{"key":"R10-17-20210202","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0264-410X(95)00007-N","article-title":"Safety, immunogenicity, and kinetics of the immune response to a single dose of virosome-formulated hepatitis A vaccine in Thais.","volume":"13","author":"Poovorawan","year":"1995","journal-title":"Vaccine"},{"key":"R11-17-20210202","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0264-410X(97)00015-7","article-title":"Immunogenicity and protectivity of a new liposomal hepatitis A vaccine.","volume":"15","author":"Ambrosch","year":"1997","journal-title":"Vaccine"},{"key":"R12-17-20210202","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1016\/S0264-410X(03)00509-7","article-title":"Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal).","volume":"21","author":"Usonis","year":"2003","journal-title":"Vaccine"},{"key":"R13-17-20210202","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1002\/jmv.21883","article-title":"Predicted 30-year protection after vaccination with an aluminum-free virosomal hepatitis A vaccine.","volume":"82","author":"Bovier","year":"2010","journal-title":"J Med Virol"},{"key":"R14-17-20210202","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1097\/INF.0b013e31806215c8","article-title":"Immunogenicity and safety of a pediatric dose of a virosome-adjuvanted hepatitis A vaccine: a controlled trial in children aged 1-16 years.","volume":"26","author":"Van Der Wielen","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R15-17-20210202","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/INF.0b013e318060acbd","article-title":"Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.","volume":"26","author":"Dagan","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R16-17-20210202","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1097\/INF.0000000000000616","article-title":"Long-term antibody persistence in children after vaccination with the pediatric formulation of an aluminum-free virosomal hepatitis A vaccine.","volume":"34","author":"VanHerck","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R18-17-20210202","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12178-011-9084-9","article-title":"Non-surgical treatment of osteoarthritis-related pain in the elderly.","volume":"4","author":"Mushtaq","year":"2011","journal-title":"Curr Rev Musculoskelet Med"},{"key":"R19-17-20210202","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0140-6736(03)14418-2","article-title":"Hepatitis A booster vaccination: is there a need?","volume":"362","author":"Van Damme","year":"2003","journal-title":"Lancet"},{"key":"R20-17-20210202","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1185\/030079907X233179","article-title":"Open-label study of the safety and effectiveness of long-term therapy with extended-release tramadol in the management of chronic nonmalignant pain.","volume":"23","author":"Pascual","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"R21-17-20210202","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/jmv.10244","article-title":"Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.","volume":"68","author":"Bovier","year":"2002","journal-title":"J Med Virol"},{"key":"R22-17-20210202","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/INF.0b013e318190655c","article-title":"The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community.","volume":"28","author":"Barkai","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R23-17-20210202","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.inf.0000247105.45185.13","article-title":"Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program.","volume":"26","author":"Belmaker","year":"2007","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000001176","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T01:11:01Z","timestamp":1620954661000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201607000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001176","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}